General Gastro News Articles

Gastro

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gisbert JP et al. - Thiopurine drugs (AZA/MP) are more effective than placebo for the prevention of relapse in UC, with an NNT of 5 and an absolute risk reduction of 23%.

Related Articles

Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09    Relevance Score: 70%

Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09    Relevance Score: 69%

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Gastroenterology, 10/06/09    Relevance Score: 68%

Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology, 10/05/09    Relevance Score: 68%

Ulcerative Colitis Treatment Reduces Need For Surgery By Almost Half, Study Suggests
ScienceDaily, 10/02/09    Relevance Score: 68%

Today in Inflammatory Bowel Dz...keeping you current

An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Therapeutics and Clinical Risk Management, 12/01/09

Appendiceal Mucocele Detected under Treatment of Ulcerative Colitis
Case Reports in Gastroenterology, 11/25/09

Pyoderma Gangrenosum in Crohn's Disease: Unusual Presentation and Management
Case Reports in Gastroenterology, 11/25/09

Today in Pharmacology/kinetics...keeping you current

An evidence-based review of natalizumab therapy in the management of Crohn’s disease
Therapeutics and Clinical Risk Management, 12/01/09

Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer
Cancer Chemotherapy and Pharmacology, 12/01/09